pros and cons of glp 1 drugs Understanding Weight Loss Medications: GLP-1 vs. Phentermine GLP-1 Explained: Benefits and Concerns

The original development partner, Janssen Pharmaceuticals, has handed back the license for efinopegdutide to the original developer, Hanmi Pharmaceutical, but the license has been taken up by Merck to be developed as a once weekly treatment for NAFLD

GLP-1 receptor agonists like semaglutide already show promise in alleviating diseases in healthy older adults, including cardiovascular disease and neurodegenerative disease

2026;DOI:10.1016/S0140-6736(26)00202-3

Some patients find 200 to 400 mg at bedtime helps with both bowel regularity and sleep

Another of his friends, who started the medication, echoed this sentiment.There are some who see it differently

Egebjerg T